Bayer partners with innovative hormone monitoring device start-up
Funding to advance early-stage research efforts
Bayer announced a partnership withImpli, an innovative, deep-tech start-up in precision care. Impli’s goal is to advance women’s health and deliver the first real-time hormone monitoring device – making fertility more accessible, safer and more successful.
Bayer is partnering with Impli, a start-up developing an innovative hormone monitoring device (illustrated here) to advance early-stage research while exploring a variety of potential use cases for hormone monitoring.
Bayer AG
With hormones playing a critical role in many of our body’s systems and functions, real-time monitoring can help unlock key insights necessary to make smarter, more precise decisions about a person’s healthcare.
Terms of the partnership were not disclosed, but it is intended to advance early-stage research while exploring a variety of potential use cases for hormone monitoring and providing Impli with access to Bayer’s global innovation ecosystem. The partnership is the result of Impli winning a Bayer-sponsored innovation challenge at the HLTH Europe conference earlier this year.
“New technologies are helping us answer one of the largest consumer unmet needs: better understanding what is happening in their own body and what it means for managing their health journey,” said Aquil Harjivan, Head of front-end innovation for the Consumer Health division of Bayer. “We are excited to join cutting-edge innovators like Impli to explore the exciting frontiers of making health care more precise for every individual.”
“Reimagining women's hormonal health is more than a challenge; it's an opportunity to innovate and transform lives. The opportunity to break barriers together with a pioneering leader in the field such as Bayer is not just exciting—it's a chance to create meaningful change and deliver better outcomes for everyone.” said Anna Luisa Schaffgotsch CEO, Impli.
Bayer sees potential for advancements across its self-care categories with deeper understanding of a person’s hormones and their potential impact on conditions like stress, sleep, weight management, cardiovascular health, women’s health, or bone health.
Accelerating Precision Health Ambitions
Since launching a new business unit focused on Precision Health, Bayer has emerged as an industry leader in partnering with innovative companies bringing new digital tools to consumers to help them manage their health. Earlier this year in the U.S., Bayer launched the One-a-Day Age Factor ecosystem to help consumers better understand and manage their personal aging journey at the cellular level.
“Each of us are on a unique health journey,” added Harjivan. “Better insights and diagnostics coupled with trusted self-care products pave the way for us all to better manage our own journeys.”
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
